Chase Brexton Healthcare offers Substance Use Treatment, Co-occurring (Substance + Mental Health). Contact us or call our helpline for a detailed breakdown of available programs and current availability.

Yes, Chase Brexton Healthcare accepts Medicaid. For qualifying residents in MD, most or all treatment costs may be covered at no out-of-pocket expense.

Yes, Chase Brexton Healthcare provides medication-assisted treatment (MAT). MAT combines FDA-approved medications such as buprenorphine or naltrexone with counseling to treat alcohol and opioid use disorders.

Yes, Chase Brexton Healthcare offers dual diagnosis treatment for individuals with co-occurring substance use and mental health disorders such as depression, anxiety, PTSD, and bipolar disorder.

Yes, Chase Brexton Healthcare provides gender-specific treatment programs for women. These programs are designed to address the unique challenges women face in recovery, including trauma, family dynamics, and co-occurring disorders.

Yes, Chase Brexton Healthcare offers treatment programs for adolescents and young adults. Youth-specific programs address developmental needs and often include family therapy components.

Yes, Chase Brexton Healthcare offers residential treatment where patients live at the facility for 30–90+ days. Residential care provides 24/7 support and is typically recommended for those with severe dependence or who need a structured environment.

Chase Brexton Healthcare is listed in the SAMHSA National Directory of Mental Health Treatment Facilities. Call our helpline to confirm current accreditation status.

Call our free helpline at 1-888-767-3708 to speak with an admissions advisor. They can verify your insurance, explain program options, and help you take the first step toward recovery — 24/7, at no cost.